Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diversified Healthcare Trust (DHCNL) Equity Income (2016 - 2025)

Historic Equity Income for Diversified Healthcare Trust (DHCNL) over the last 17 years, with Q3 2025 value amounting to $5.1 million.

  • Diversified Healthcare Trust's Equity Income rose 86451.61% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year increase of 15492.99%. This contributed to the annual value of $1.6 million for FY2024, which is 10780.51% up from last year.
  • Diversified Healthcare Trust's Equity Income amounted to $5.1 million in Q3 2025, which was up 86451.61% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Diversified Healthcare Trust's Equity Income ranged from a high of $11.5 million in Q4 2024 and a low of -$28.6 million during Q4 2023
  • Moreover, its 5-year median value for Equity Income was -$1.4 million (2022), whereas its average is -$3.7 million.
  • Per our database at Business Quant, Diversified Healthcare Trust's Equity Income crashed by 56854.54% in 2023 and then soared by 86451.61% in 2025.
  • Diversified Healthcare Trust's Equity Income (Quarter) stood at -$15.3 million in 2021, then soared by 72.03% to -$4.3 million in 2022, then plummeted by 568.55% to -$28.6 million in 2023, then surged by 140.15% to $11.5 million in 2024, then crashed by 55.72% to $5.1 million in 2025.
  • Its Equity Income was $5.1 million in Q3 2025, compared to $3.1 million in Q2 2025 and $1.5 million in Q1 2025.